154 related articles for article (PubMed ID: 6517224)
21. Localized resectable neuroblastoma: results of the second study of the Italian Cooperative Group for Neuroblastoma.
De Bernardi B; Conte M; Mancini A; Donfrancesco A; Alvisi P; Tomà P; Casale F; Cordero di Montezemolo L; Cornelli PE; Carli M
J Clin Oncol; 1995 Apr; 13(4):884-93. PubMed ID: 7707115
[TBL] [Abstract][Full Text] [Related]
22. Multivariate analysis of risk factors for patients with stage 4 neuroblastoma who were older than 18 months at diagnosis: a report from a single institute in Shanghai, China.
Cai J; Pan C; Tang Y; Chen J; Zhou M; Li B; Xue H; Shen S; Gao Y; Zhang A; Tang J
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1327-1335. PubMed ID: 28283783
[TBL] [Abstract][Full Text] [Related]
23. Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers.
Cheung NK; Kushner BH; LaQuaglia MP; Kramer K; Ambros P; Ambros I; Ladanyi M; Eddy J; Bonilla MA; Gerald W
Eur J Cancer; 1997 Oct; 33(12):2117-20. PubMed ID: 9516865
[TBL] [Abstract][Full Text] [Related]
24. Thoracic neuroblastic tumors in childhood.
Demir HA; Yalçin B; Büyükpamukçu N; Kale G; Varan A; Akyüz C; Kutluk T; Büyükpamukçu M
Pediatr Blood Cancer; 2010 Jul; 54(7):885-9. PubMed ID: 20049935
[TBL] [Abstract][Full Text] [Related]
25. [Tumours in newborns and infants up to three months of life. One institution experience].
Perek D; Brozyna A; Dembowska-Baginska B; Stypinska M; Sojka M; Bacewicz L; Polnik D; Kalicinski P
Med Wieku Rozwoj; 2006; 10(3 Pt 1):711-23. PubMed ID: 17317902
[TBL] [Abstract][Full Text] [Related]
26. [Neuroblastoma in Costa Rica: the experience with 76 cases treated at the Hospital Nacional de Niños].
Lobo-Sanahuja F; Carranza A; García I; Barrantes M; Camacho-Morales A
Bol Med Hosp Infant Mex; 1991 Jun; 48(6):426-33. PubMed ID: 1910558
[TBL] [Abstract][Full Text] [Related]
27. Improved survival in neuroblastoma using multimodality therapy.
Rosen EM; Cassady JR; Frantz CN; Kretschmar C; Levey R; Vawter G; Sallan SE
Radiother Oncol; 1984 Oct; 2(3):189-200. PubMed ID: 6441972
[TBL] [Abstract][Full Text] [Related]
28. Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study.
Schmidt ML; Lukens JN; Seeger RC; Brodeur GM; Shimada H; Gerbing RB; Stram DO; Perez C; Haase GM; Matthay KK
J Clin Oncol; 2000 Mar; 18(6):1260-8. PubMed ID: 10715296
[TBL] [Abstract][Full Text] [Related]
29. Infantile neuroblastoma: 10 year TMH experience.
Rao SR; Iyer RS; Nair CN; Kurkure PA; Pai SK; Advani SH
Indian J Cancer; 1993 Jun; 30(2):85-7. PubMed ID: 8225383
[TBL] [Abstract][Full Text] [Related]
30. Neuroblastoma. Evaluation of 60 cases.
Carlsen NL; Nielsen OH; Hertz H
Acta Paediatr Scand; 1981 Jan; 70(1):61-6. PubMed ID: 7211378
[TBL] [Abstract][Full Text] [Related]
31. [Treatment results of neuroblastoma in children in the Republic of Belarus].
Proleskovskaia IV; Savich TV; Mareĭko IuE; Savva NN; Aleĭnikova OV
Vopr Onkol; 2009; 55(2):215-20. PubMed ID: 19514379
[TBL] [Abstract][Full Text] [Related]
32. Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy.
Matthay KK; Sather HN; Seeger RC; Haase GM; Hammond GD
J Clin Oncol; 1989 Feb; 7(2):236-44. PubMed ID: 2915240
[TBL] [Abstract][Full Text] [Related]
33. [Clinical features and prognosis of advanced neuroblastoma in children].
Gao XN; Tang SQ; Lin J
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):351-4. PubMed ID: 17706038
[TBL] [Abstract][Full Text] [Related]
34. Incidental neuroblastoma.
Armata J; Dłuniewska A; Garus K; Balwierz W; Mieyński W; Hnatko-Kołacz M
Pediatr Hematol Oncol; 2000 Dec; 17(8):673-8. PubMed ID: 11127399
[TBL] [Abstract][Full Text] [Related]
35. [Prognostic factors in neuroblastoma. Usefulness of DNA analysis using flow cytometry on paraffin-embedded material].
Massara FM; Tonello M; Forni M; Fruttero A; Lantermo R; Pugno F; Cordero di Montezemolo L; Ruà S
Pediatr Med Chir; 1996; 18(2):141-8. PubMed ID: 8767575
[TBL] [Abstract][Full Text] [Related]
36. Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study.
Perez CA; Matthay KK; Atkinson JB; Seeger RC; Shimada H; Haase GM; Stram DO; Gerbing RB; Lukens JN
J Clin Oncol; 2000 Jan; 18(1):18-26. PubMed ID: 10623689
[TBL] [Abstract][Full Text] [Related]
37. Neuroblastoma--a surgical perspective.
Losty P; Quinn F; Breatnach F; O'Meara A; Fitzgerald RJ
Eur J Surg Oncol; 1993 Feb; 19(1):33-6. PubMed ID: 8436238
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in neuroblastoma.
Kajanti M; Holsti P
Ann Clin Res; 1986; 18(3):129-33. PubMed ID: 3740789
[TBL] [Abstract][Full Text] [Related]
39. The Pediatric Oncology Group experience with the international staging system criteria for neuroblastoma. Member Institutions of the Pediatric Oncology Group.
Castleberry RP; Shuster JJ; Smith EI
J Clin Oncol; 1994 Nov; 12(11):2378-81. PubMed ID: 7964953
[TBL] [Abstract][Full Text] [Related]
40. Postoperative treatment of nonmetastatic visible residual neuroblastoma: a Pediatric Oncology Group study.
Nitschke R; Smith EI; Altshuler G; Altmiller D; Shuster J; Green A; Castleberry R; Hayes FA; Golembe B; Ducos R
J Clin Oncol; 1991 Jul; 9(7):1181-8. PubMed ID: 2045858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
